Joseph P. Neglia
University of Minnesota
284 Papers
1.7K Citations
Joseph P. Neglia is an academic researcher from University of Minnesota. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 72, co-authored 241 publications. Previous affiliations of Joseph P. Neglia include Children's Oncology Group & Fred Hutchinson Cancer Research Center.
Chat about Author
Papers
Poverty during Maintenance and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): A Report from Children's Oncology Group Study (COG-AALL03N1)
Aman Wadhwa,Yanjun Chen,Lindsey Hageman,Anna Hoppmann,Anne L. Angiolillo,David S. Dickens,Glen Lew,Joseph P. Neglia,Yaddanapudi Ravindranath,A. Kim Ritchey,Amanda M. Termuhlen,Lennie Wong,Wendy Landier,Smita Bhatia +13 more
TL;DR: Bona et al. as mentioned in this paper found that extreme household poverty is associated with increased risk of relapses in children with ALL compared to those living in the US without extreme poverty, and the reasons for the association between individual level poverty and relapse risk are likely multifactorial and possibly include poor adherence to oral chemotherapy.
Reply to Second malignancies in Ewing sarcoma survivors.
Neyssa Marina,Qi Liu,Sarah S. Donaldson,Charles A. Sklar,Gregory T. Armstrong,Kevin C. Oeffinger,Wendy M. Leisenring,Jill P. Ginsberg,Tara O. Henderson,Joseph P. Neglia,Marilyn Stovall,Yutaka Yasui,R. Lor Randall,David S. Geller,Leslie L. Robison,Kirsten K. Ness +15 more
TL;DR: Survivors of ES have a significantly increased risk of both solid and hematologic SMNs, and there is an increase in the O/E ratio for hematological SMNs in the SEER cohort (O/E for acute myeloid leukemia, 71 vs 29).
childhood acute lymphoblastic leukemia randomized to dexamethasone or prednisone in the treatment of A comparison of neurocognitive functioning in children previously
Megan Nicoletti,Linda C. Stork,Bruce Bostrom,Joseph P. Neglia,Nina S. Kadan-Lottick,Pim Brouwers,David Breiger,Thomas A. Kaleita,James Dziura,Haibei Liu +9 more
- 01 Jan 2013
Randomized comparison of cyclophosphamide-total
Kathryn E. Dusenbery,Kathleen Daniels,Philip B. McGlave,Norma K.C. Ramsay,Bruce R. Blazar,Joseph P. Neglia,John H. Kersey,William G. Woods +7 more
- 01 Jan 1995
TL;DR: Cyclophosphamide-total body irradiation provided an equivalent or better outcome to BU/CY, particularly in advanced patients, and should remain the standard by which new regimens are judged.